Journal of Oncology / 2019 / Article / Tab 1

Research Article

Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer

Table 1

Characteristics of patients with LAPC undergoing IRE therapy.

CharacteristicsNumberPercentage (%)

Patients34100
Age (years)≤ 601955.9
> 601544.1
GenderFemale1852.9
Male1647.1
Tumor size (cm)≤ 212.9
2~41955.9
>41441.2
Tumor gradeWell25.9
Moderate1955.9
Poor1338.2
Tumor siteHead1750.0
Body / Tail1750.0
WBC (109)≤ 103088.2
> 10411.8
HGB (g/L)≤ 1201029.4
> 1202470.6
PLT (109)≤ 3002985.3
> 300514.7
ALT (U/L)≤ 402573.5
> 40926.5
AST (U/L)≤ 402882.4
> 40617.6
ALP (U/L)≤ 1001852.9
> 1001647.1
GGT (U/L)≤ 451852.9
> 451647.1
ALB (g/L)≤ 4038.8
> 403191.2
TBIL (umol/L)≤ 20.52676.5
> 20.5823.5
IBIL (umol/L)≤ 153088.2
> 15411.8
CRP (ng/L)≤ 32573.5
> 3926.5
CEA (ng/mL)≤ 52058.8
> 51441.2
CA19-9 (U/ml)≤ 35823.5
> 352676.5
NLR≤ 1.47926.5
> 1.472573.5
PLR≤ 165.292264.7
> 165.291235.3
PI02573.5
1926.5
mGPS02985.3
1411.8
212.9

LAPC, locally advanced pancreatic cancer; IRE, irreversible electroporation; WBC, white blood cell count; PLT, platelet count; ALT, alanine transaminase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, glutamyl transpeptidase; ALB, albumin; TBIL, total bilirubin; IBIL, indirect bilirubin; CRP, C-reactive protein; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; PI, prognostic index; mGPS, modified Glasgow Prognostic Score.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.